Global Pharmacovigilance Market Size, Status and Forecast 2019-2025


Report ID : RNR-265034 Category : Pharma Healthcare Published Date : March-2019
Publisher : Research-N-Reports Pages : 125 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

In 2018, the global Pharmacovigilance market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Pharmacovigilance status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacovigilance development in United States, Europe and China.

The key players covered in this study

- Eli Lilly and Company

- ICON plc

- Elsevier

- Chiltern

- Atlantic Research Group

- Mapi Group

- Accenture Plc.

- Clinquest Group B.V.

- GSK

- PRA Health Sciences, Inc.

Market segment by Type, the product can be split into

- Chemotherapy

- Contract Outsourcing

Market segment by Application, split into

- Pharma and Biotech Companies

- Contract Research Organizations (CROs)

- Business Process Outsourcing (BPO) Firms

- Other Pharmacovigilance Service Providers

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Pharmacovigilance status, future forecast, growth opportunity, key market and key players.

- To present the Pharmacovigilance development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacovigilance are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacovigilance Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Contract Outsourcing
1.5 Market by Application
1.5.1 Global Pharmacovigilance Market Share by Application (2014-2025)
1.5.2 Pharma and Biotech Companies
1.5.3 Contract Research Organizations (CROs)
1.5.4 Business Process Outsourcing (BPO) Firms
1.5.5 Other Pharmacovigilance Service Providers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pharmacovigilance Market Size
2.2 Pharmacovigilance Growth Trends by Regions
2.2.1 Pharmacovigilance Market Size by Regions (2014-2025)
2.2.2 Pharmacovigilance Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pharmacovigilance Market Size by Manufacturers
3.1.1 Global Pharmacovigilance Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacovigilance Key Players Head office and Area Served
3.3 Key Players Pharmacovigilance Product/Solution/Service
3.4 Date of Enter into Pharmacovigilance Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pharmacovigilance Market Size by Type (2014-2019)
4.2 Global Pharmacovigilance Market Size by Application (2014-2019)
5 United States
5.1 United States Pharmacovigilance Market Size (2014-2019)
5.2 Pharmacovigilance Key Players in United States
5.3 United States Pharmacovigilance Market Size by Type
5.4 United States Pharmacovigilance Market Size by Application
6 Europe
6.1 Europe Pharmacovigilance Market Size (2014-2019)
6.2 Pharmacovigilance Key Players in Europe
6.3 Europe Pharmacovigilance Market Size by Type
6.4 Europe Pharmacovigilance Market Size by Application
7 China
7.1 China Pharmacovigilance Market Size (2014-2019)
7.2 Pharmacovigilance Key Players in China
7.3 China Pharmacovigilance Market Size by Type
7.4 China Pharmacovigilance Market Size by Application
8 Japan
8.1 Japan Pharmacovigilance Market Size (2014-2019)
8.2 Pharmacovigilance Key Players in Japan
8.3 Japan Pharmacovigilance Market Size by Type
8.4 Japan Pharmacovigilance Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pharmacovigilance Market Size (2014-2019)
9.2 Pharmacovigilance Key Players in Southeast Asia
9.3 Southeast Asia Pharmacovigilance Market Size by Type
9.4 Southeast Asia Pharmacovigilance Market Size by Application
10 India
10.1 India Pharmacovigilance Market Size (2014-2019)
10.2 Pharmacovigilance Key Players in India
10.3 India Pharmacovigilance Market Size by Type
10.4 India Pharmacovigilance Market Size by Application
11 Central & South America
11.1 Central & South America Pharmacovigilance Market Size (2014-2019)
11.2 Pharmacovigilance Key Players in Central & South America
11.3 Central & South America Pharmacovigilance Market Size by Type
11.4 Central & South America Pharmacovigilance Market Size by Application
12 International Players Profiles
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacovigilance Introduction
12.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2014-2019)
12.1.5 Eli Lilly and Company Recent Development
12.2 ICON plc
12.2.1 ICON plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacovigilance Introduction
12.2.4 ICON plc Revenue in Pharmacovigilance Business (2014-2019)
12.2.5 ICON plc Recent Development
12.3 Elsevier
12.3.1 Elsevier Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacovigilance Introduction
12.3.4 Elsevier Revenue in Pharmacovigilance Business (2014-2019)
12.3.5 Elsevier Recent Development
12.4 Chiltern
12.4.1 Chiltern Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacovigilance Introduction
12.4.4 Chiltern Revenue in Pharmacovigilance Business (2014-2019)
12.4.5 Chiltern Recent Development
12.5 Atlantic Research Group
12.5.1 Atlantic Research Group Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacovigilance Introduction
12.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2014-2019)
12.5.5 Atlantic Research Group Recent Development
12.6 Mapi Group
12.6.1 Mapi Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacovigilance Introduction
12.6.4 Mapi Group Revenue in Pharmacovigilance Business (2014-2019)
12.6.5 Mapi Group Recent Development
12.7 Accenture Plc.
12.7.1 Accenture Plc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacovigilance Introduction
12.7.4 Accenture Plc. Revenue in Pharmacovigilance Business (2014-2019)
12.7.5 Accenture Plc. Recent Development
12.8 Clinquest Group B.V.
12.8.1 Clinquest Group B.V. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacovigilance Introduction
12.8.4 Clinquest Group B.V. Revenue in Pharmacovigilance Business (2014-2019)
12.8.5 Clinquest Group B.V. Recent Development
12.9 GSK
12.9.1 GSK Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmacovigilance Introduction
12.9.4 GSK Revenue in Pharmacovigilance Business (2014-2019)
12.9.5 GSK Recent Development
12.10 PRA Health Sciences, Inc.
12.10.1 PRA Health Sciences, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmacovigilance Introduction
12.10.4 PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2014-2019)
12.10.5 PRA Health Sciences, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details